Soluble CD40L and cardiovascular risk in women

Circulation

Volumn 104, Issue 19, 2001, Pages 2266-2268

  Schönbeck, Uwe ^a   Varo, Nerea ^a   Libby, Peter ^a   Buring, Julie ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Immune system; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; CD40 ANTIGEN; CYTOKINE; GLYCOPROTEIN GP 39; PLACEBO;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0035818509     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4401.099447     Document Type: Article

References (13)

1. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
2. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection
3. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
4. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
5. The CD40/CD154 receptor/ligand dyad
6. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
7. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
8. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
9. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation
10. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
11. The women's health study: Summary of the study design
12. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
13. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men